SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PROTEOMICS

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jongmans who started this subject4/7/2001 5:36:58 AM
From: d:oug   of 539
 
This tiny little mouse, might it roar or be that train that can?

Boy will I feel dumb if I'm on the wrong subject thread.

This does not add up, as how can this company have
a superior "mouse trap" that cost less, much faster,
able to handle special cases and deliver more accurate
results containing more information.

For sure you would expect to hear this 3 a.m. on t.v.
as an info commercial... "... and if you act now you
will receive at no extra cost..."

Haber, Inc.
It's technology is called Electromolecular Propulsion (EMP).
EMP opportunities in the field of Proteomics.

April 6, 2001 -- Company Update - Haber, Inc.

haberscience.com

Meetings with Proteomics Professionals.

... in view of the developments in the field of Proteomics,
a group of advisors and consultants was assembled to help
the company prioritize the opportunities for its EMP technology.

Haber, Inc. has done considerable work on protein separations.

... to complete the human genome
... the characterization of 30,000 important genes
... are only important for the proteins that they incode

... the vastly superior speed of EMP compared to electrophoresis
may become an opportunity in the new field of Protenomics.

... in the analysis of the folding pathways of proteins,
IBM has committed $100 million to design and build advanced
supercomputers for this purpose. This is a five-year project
in a market projected to be $9.5 billion by 2003.

Overall expenditures for drug discovery tools are estimated
at about 50% of the $36-40 billion R&D effort.....

... the Haber technology called Electromolecular Propulsion (EMP),
is an ultra-high speed analytical technology... this technology,
unlike electrophoresis, will enable analytical work with the more
subtle non-ionic characteristics of the proteins... will change
the mode of separation and analytical details corresponding to
a protein's configuration. Having already achieved feasibility
with a broad variety proteins, the entry of EMP into the field
of proteomics signifies a bright new high-resolution technology
needed to accelerate and expand the scope of proteomics.

This Company Update contains forward-looking statements
as defined by the Private Securities Litigation Reform Act...

HABE -- Haber, Inc.
Best Bid: 0.03
Best Ask: 0.034
Primary Venue: Pink Sheets
Haber Inc. financials are current and Haber's market maker
has filed for relisting onto the OTC Electronic Bulletin Board...

5 year share price graph
pinksheets.com

HABE -- Haber, Inc.
470 Main Rd. Towaco, NJ 07082-1294 USA
Company Website: haberscience.com
Shares Outstanding: 84,766,800 as of 2000-02-29
Dividends: None
State of Incorporation: DE
Transfer Agents:
Continental Stock Transfer & Trust Co., Jersey City, NJ 07302
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext